Back

Tranexamic acid effectively inhibits fibrinolysis in the presence of anticoagulant and antiplatelet medications

18 March 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 1 - Atrial fibrillation - Clinical Acute Therapy EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Jonathan Goodman

Fridley (United States of America)

28 More presentations in this session

Presentation thumbnail
Doctor S. Ouali (Tunis, TN)
Abstract Slides
Presentation thumbnail
Doctor S. Ouali (Tunis, TN)
Abstract Slides
Presentation thumbnail
Doctor A. Margulescu (Swansea, GB)
Abstract Slides
Presentation thumbnail
Associate Professor J. Kornej (Dresden, DE)
Abstract
Presentation thumbnail
Associate Professor K. Lee (Gwangju, KR)
Abstract Slides

Access the full session

Session thumbnail
Poster session 1 - Atrial fibrillation - Clinical

The Event

Event poster

EHRA 2018

18 March 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Prevention of bleeding complications with local tranexamic acid use during cardiovascular implantable electronic device implantation
13 April 2026
thumbnail
Congress Session
State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?
14 March 2025
thumbnail
Congress Presentation
Contemporary thrombosis management -- state of the state
30 August 2024
thumbnail
Congress Presentation
Perioperative management of antithrombotic therapy.
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources